Tim M. Mayleben
2021 - Landos Biopharma
In 2021, Tim M. Mayleben earned a total compensation of $1.1M as President, Chief Executive Officer and Director at Landos Biopharma.
Compensation breakdown
Option Awards | $1,020,375 |
---|---|
Salary | $79,905 |
Other | $33,769 |
Total | $1,134,049 |
Mayleben received $1M in option awards, accounting for 90% of the total pay in 2021.
Mayleben also received $79.9K in salary and $33.8K in other compensation.
Rankings
In 2021, Tim M. Mayleben's compensation ranked 8,359th out of 12,406 executives tracked by ExecPay. In other words, Mayleben earned more than 32.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 8,359 | 33rd |
Manufacturing | 3,699 | 33rd |
Chemicals And Allied Products | 1,646 | 31st |
Drugs | 1,464 | 30th |
Pharmaceutical Preparations | 1,089 | 29th |
Mayleben's colleagues
We found four more compensation records of executives who worked with Tim M. Mayleben at Landos Biopharma in 2021.
News
Landos Biopharma CEO Gregory Oakes receives $1.8M in 2022
April 19, 2023
Landos Biopharma Executive Vice President of Operations Jyoti RAC's 2021 pay jumps 195% to $2.8M
April 28, 2022
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Esperion Therapeutics CEO Tim Mayleben's 2019 pay falls 89% to $1.1M
April 16, 2020
Esperion Therapeutics CEO Tim Mayleben's 2018 pay jumps 94% to $9.7M
April 18, 2019